Bridgeway Capital Management’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-34,900
| Closed | -$14.7K | – | 1263 |
|
|
2024
Q4 | $14.7K | Sell |
34,900
-5,100
| -13% | -$2.14K | ﹤0.01% | 1188 |
|
|
2024
Q3 | $19K | Sell |
40,000
-45,000
| -53% | -$21.4K | ﹤0.01% | 1245 |
|
|
2024
Q2 | $44K | Hold |
85,000
| – | – | ﹤0.01% | 1231 |
|
|
2024
Q1 | $66.8K | Hold |
85,000
| – | – | ﹤0.01% | 1248 |
|
|
2023
Q4 | $249K | Hold |
85,000
| – | – | 0.01% | 1092 |
|
|
2023
Q3 | $192K | Hold |
85,000
| – | – | ﹤0.01% | 1109 |
|
|
2023
Q2 | $183K | Hold |
85,000
| – | – | ﹤0.01% | 1154 |
|
|
2023
Q1 | $188K | Buy |
85,000
+25,000
| +42% | +$55.3K | 0.01% | 1117 |
|
|
2022
Q4 | $66K | Hold |
60,000
| – | – | ﹤0.01% | 1273 |
|
|
2022
Q3 | $82K | Hold |
60,000
| – | – | ﹤0.01% | 1307 |
|
|
2022
Q2 | $104K | Sell |
60,000
-186,327
| -76% | -$323K | ﹤0.01% | 1216 |
|
|
2022
Q1 | $495K | Buy |
246,327
+36,463
| +17% | +$73.3K | 0.01% | 940 |
|
|
2021
Q4 | $936K | Buy |
+209,864
| New | +$936K | 0.02% | 803 |
|